The global Glaucoma Therapeutics Market, valued at USD 7.25 million in 2023, is on a robust growth trajectory and is expected to reach USD 9.62 million by 2031. This represents a compound annual growth rate (CAGR) of 3.6% over the forecast period from 2024 to 2031. Key Players Some major players in Glaucoma Therapeutics Market are Merck & Co. Inc, Allergan, Bausch & Lomb...

The Booming Potential of 3D Bioprinting Market: Revolutionizing Healthcare The 3D bioprinting market is witnessing a surge in growth, driven by its immense potential to revolutionize healthcare. This technology allows for the creation of three-dimensional structures using biocompatible materials and living cells. This paves the way for advancements in tissue engineering, drug discovery, and...

Biosimilars Market size was valued at USD 25.10 Billion in 2022 and is expected to reach USD 91.81 Billion By 2030 and grow at a CAGR of 17.6% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Significant cost savings: Biosimilars, highly similar versions of existing biologic drugs, offer substantial cost...

The Autoimmune Disease Therapeutics Market size was valued at USD 72.05 billion in 2022 and it is expected to be worth around USD 94.87 billion by 2030 growing at a remarkable CAGR of 3.5% over the forecast period 2023-2030. Several key factors are propelling this market growth: Rising prevalence of autoimmune diseases: Conditions like rheumatoid...

The global size of bioanalytical testing services market in terms of revenue was estimated to be worth USD 2.9 billion in 2022 and is poised to reach USD 6.0 billion by 2027, growing at a CAGR of 15.6% from 2022 to 2027. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12254971 Factors such as the rising focus on the analytical testing of biologics and biosimilars,...

The global bioanalytical testing services market is poised for robust growth in the coming years, according to a new report from MarketsandMarkets. The market was valued at $2.9 billion in 2022 and is projected to reach $6.0 billion by 2027, growing at a compound annual growth rate (CAGR) of 15.6% during the forecast period. Request for Free Sample Report Bioanalytical testing services support...

Biofabrication is an emerging technological field that focuses on manufacturing structures for tissue engineering and regenerative medicine. This field has gained significant attention in recent years due to its potential to revolutionize the healthcare industry. In this article, we will explore the biofabrication market, its size, growth projections, and the key factors driving its growth....

The global biological safety testing market, which was valued at USD 4.32 billion in 2022, is projected to reach USD 12.98 billion by 2032, with a compound annual growth rate (CAGR) of 13% throughout the forecast period. The growth of biologics and biosimilars in the pharmaceutical and biotechnology industries is a significant factor contributing to the increasing market revenue. The demand for...

The Biopharmaceuticals Manufacturing Consumables Testing Market is predicted to increase from USD 3.93 billion in 2022 to USD 7.23 billion in 2032, with a revenue CAGR of 7%. The growth is due to increasing investments in biopharmaceutical research and development and the rising demand for biopharmaceuticals. The need for high-quality consumables, such as bioreactors, filtration systems, and...

The global bioprocess containers market size is projected to reach USD 9.6 billion by 2026, at a CAGR of 26.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832 Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising...